Update on Uterine Mesenchymal Neoplasms.
| Autor: | Kertowidjojo EC; Department of Pathology, University of Chicago Medicine, 5837 South Maryland Avenue, MC 6101, Chicago, IL 60637, USA., Bennett JA; Department of Pathology, University of Chicago Medicine, 5837 South Maryland Avenue, MC 6101, Chicago, IL 60637, USA. Electronic address: jabennett@bsd.uchicago.edu. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Surgical pathology clinics [Surg Pathol Clin] 2022 Jun; Vol. 15 (2), pp. 315-340. Date of Electronic Publication: 2022 May 20. |
| DOI: | 10.1016/j.path.2022.02.008 |
| Abstrakt: | This review focuses on recent advances in epithelioid and myxoid uterine mesenchymal neoplasms, a category of tumors whereby diagnostic criteria have been rapidly evolving due to advances in molecular testing. Pertinent clinicopathological and molecular features are highlighted for perivascular epithelioid cell tumors, uterine tumors resembling ovarian sex cord tumors, BCOR/BCORL1-altered high-grade endometrial stromal sarcomas, and inflammatory myofibroblastic tumors. Novel developments in epithelioid and myxoid leiomyosarcomas are briefly discussed, and differential diagnoses with key diagnostic criteria are provided for morphologic mimickers. Competing Interests: Disclosure The authors have nothing to disclose. (Copyright © 2022 Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|